This document lists the collaborations and conflicts of interest for speakers Thomas F. Lüscher and Marco Metra. It notes that they have received research grants, educational grants, and honoraria from numerous pharmaceutical companies. The rest of the document discusses the European Heart Journal, including new associate editors, submission rates and acceptance rates, impact factors, and plans to launch new open access and supplement journals.

1. The EHJ’s and EJHF’s
Year in Cardiology
ESC Heart Failure Association
Annual Congress
Sevilla May 23, 2015
Thomas F. Lüscher, MD, FESC, FACC
and
Marco Metra, MD, FESC

2. Collaborations and Consultancies (Conflicts of Interest)
Abbott Laboratories (Research Grants)
Actelion, Basel, Switzerland (Educational Grants)
Amgen, Zug, Switzerland (Research Grants, Honoraria)
AstraZeneca, Zug, Switzerland (Research Grants, Honoraria)
Bayer HealthCare, Berlin and Zurich (Research and Educational Grants, Honoraria)
Biotronik, Baar, Switzerland (Research Grants)
Biosensors International (Research Grants)
Boehringer Ingelheim, Basel, Switzerland (Educational Grants and Honoraria)
Boston Scientific, Zurich and Paris (Research Grants, Honoraria)
Daichi Sankyo, Japan and Zurich (Research Grants, Honoraria)
Eli Lilly, Indianapolis, U.S.A. und Verneir, Switzerland (Research Grants and Honoraria)
Edwards (Research Grants)
MERCK Inc., Rahway, N.J., U.S.A. (Research Grants and Honoraria)
Medicines Company (Educational Grants)
A. Menarini (Educational Grants)
Merck, Sharpe and Dhome,
Novartis, Basel, Switzerland (Educational Grants)
Pfizer, Inc. New York (Research Grants and Honoraria)
Pfizer Schweiz A.G., Zurich, Switzerland (Educational Grants)
Roche, Basel, Switzerland (Research Grants and Honoraria)
Roche Diagnostics, Rotkreuz, Switzerland (Research Grants)
Sanofi, Bridgewater, N.J., U.S.A. (Honoraria)
Servier (Research and Educational Grants, Honoraria)
St. Jude, Zurich and Brussels (Educational Grants and Honoraria)
Sorin (Research Grants)

3. Main Editors
Thomas F.Thomas F. LüscherLüscher
Editor-in-ChiefEditor-in-Chief
Gerd Hindricks
Arrhythmias
Devices
Bernard Gersh
General
Cardiology
Frank Ruschitzka
Hypertension
Heart Failure
Ulf Landmesser
Basic Science
Prevention
William Wijns
Interventional
Cardiology
Jereon Bax
Imaging

4. • Suzanne Dedecke
• Amelia Meier Betscheleit
• Sam Rogers
• Johanna Huggler
• Sandra S. Guyer
Editorial Managers

5. Speaker
The EHJ is Global – Associate Editors

6. New Associate Editor of Reviews
Freek Verheught, MD, FESC
Responsibility:
• Acquisitiion of high quality
review articles
• Handling editor of reviews
The EHJ publishes 2 review
articles and/or Current
Opinions per issue
Thus, we need 90 – 100 per
year

7. Speaker
New Consulting Editor
Anthony DeMaria, MD, FACC
Will handle papers of:
• Editors
• Professionals close to editors
• Special situations

8. The Best Reviewers 2011 - 2014
Gerd Heusch
2011
Kurt Huber
2014
Johann Auer
2012
Nico van de Veire
2013

9. EHJ Acceptance Rate
Accept
10%
Reject
39%
Reject
not
reviewed
35%
Transfer
17%
Accept
15%
Reject
39%
Reject
not
reviewed
33%
Transfer
13%
2013 2014
Final Decisions of papers submitted in the given year.
Acceptance Rate of Submissions

10. • More than 20 articles in 2014.
• FastTrack articles receive first
editorial decision within 5 days and
online publication within 10 days of
acceptance.
• Authors can petition for FAST
TRACK status by sending their
manuscript by e-mail to:
fasttrack.eurheartj@usz.ch, with an
accompanying cover letter detailing
why the manuscript would be
suitable for fast track publication.
FastTrack Clinical Research
New Feature
Brief Communication
1‘500 words, 1 figure, 12 references

11. Article downloads per year
2010 2011 2012 2013 2014
0
100000000000
200000000000
300000000000
400000000000
500000000000
600000000000
Totaldownloads
HTML
PDF
2m 2.3m 2.7m 3.7m 5.6m
Influence - Downloads per Year

12. EHJ Impact Factor
7.341 7.286 7.924 8.917 9.800 10.052 10.478 14.097 14.723 14.876
EHJ’s Impact Factor has more than doubled since 2005.
2013 IF (latest) = Citations in 2013 of papers from 2011 & 2012
2014 IF due summer 2015 – Predicted to increase to approximately 14.876
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
0
2
4
6
8
10
12
14
16
ImpactFactor
Prediction:
Impact Factor over Time

13. The ESC Journal Family 2015
Now 14 Journals...

14. Editor-in-Chief
Marco Metra, MD, FESC

15. Manuscript Submissions
since 2003
15
305
408
493
591
673
644 639
803 812
842
970
1015
420
Ms Received
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015*
0
200
400
600
800
1000
1200
* 22 May 2015

16. Name Country Area of Expertise
Ali Ahmed USA Epidemiology/Outcomes/Aging
Javed Butler USA Clinical Trials/Acute HF
Kevin Damman Netherlands Comorbidities
Kenneth Dickstein Norway Electrical Devices
Gregg Fonarow USA Quality/Outcomes
Mihai Gheorghiade USA/Italy Clinical Trials/Acute HF
Barry Greenberg USA Clinical Trials/Gene Transfer
John Parissis Greece Acute/Adv HF/Rehabilitation
Burkert Pieske Austria HFpEF
Bertram Pitt USA Clinical Trials
Mark Richards NZ/Singapore Biomarkers
Giuseppe Rosano UK Pharmacology
Jillian Riley UK Telemonitoring
Peter van der Meer Netherlands Comorbidities
16
International Associate Editors

17. Name Area of Expertise Name Area of Expertise
Eloisa Arbustini Heritable CV Disease Andrea Mortara Telemonitoring/Autonomic
Function
Luigi Badano Imaging/Valve Disease Savina Nodari Quality/Outcomes
Simona Barlera Statistics/Trials Fabrizio Oliva Transplantation/Acute HF
Giuseppe Boriani Arrhythmia/Devices Luigi Padeletti Arrhythmias/Devices
Claudio Ceconi Basic Science/Biomarkers Massimo Piepoli Exercise/Secondary
Prevention
Fiorenzo Gaita Arrhythmias/Devices Michele Senni Epidemiology/Diastolic
Function
Antonello Gavazzi Clinical
Cardiology/Outcomes
Gianfranco Sinagra Genetics/Cardiomyopathies
Guido Iaccarino Basic Science/Biomarkers Gian Paolo Ussia Intervention/Valvular Heart
Disease
Roberto Latini Biomarkers/Cardiac
imaging/Pharmacology
Giorgio Vescovo Pathophysiology/
Pharmacology
Massimo Lombardi Cardiac Imaging Maurizio Volterrani Exercise/Clinical Cardiology
17
National Associate Editors

18. 18
Submissions By Type &
% Accepted – 2014/15 (to date)
2014
No. Submitted/
accepted
2014, %
Accepted
2015 No.
Submitted/
accepted
2015, %
Accepted
Book Review 1/ 0 0 0/ 0 0
Letters 17/ 6 35.3% 2/ 1 50%
Editorials 11/ 9 81.8% 3/ 2 66.6%
Invited editorials 11/ 11 100 15 /15 100%
Reviews 34/ 5 14.7% 28/ 6 21.4%
Case Reports 67/ 0 0 28/ 0 0
Full Length Articles 756/ 71 9.3% 304/ 35 11.5%
EHJ transfers 47/ 40 85.1% 19/ 16 84.2%
Short Reports 29/ 0 0 11/ 2 18.2%
Study Design 22/ 3 13.6 10/ 3 30%
Total 1015/ 151 14.9 420/ 80 19.0%

19. Sucessful Launch of EHJ – CV Pharmacotherapy
Stefan Agewall, MD, FESC
Editor-in-Chief

20. Adam Timmis, Editor-in-Chief
Adam Timmis is Professor of Clinical Cardiology in the NIHR Biomedical
Research Unit at BartsHealth Queen Mary University London. He chaired
NICE guideline groups on investigation of stable chest pain (2010) and
management of angina (2011), reviewed and co-authored the ESC stable
angina guideline (2013), was former Editor of Heart (2006-2013), and is an
executive member of the UK’s Farr Institute of Health Informatic’s Research
and the National Institute of Cardiovascular Outcomes Research.
A new ESC Journal – EHJ - QCCO

21. EHJ Supplement – The Heart of the Matter
Supplements Editor
Roberto Ferrari
Supplements Associate Editors
Francisco Fernández-Aviles
Jeroen Bax
Michael Böhm
Thomas Lüscher
Frank Ruschitzka
2013 Impact Factor: 5.6!
A new ESC Journal – EHJ Supplement
This year 14 issues are scheduled
Return to Pubmed is in process

22. Open Access
A new Open Access Journal

23. ESC Journal Family Impact Factors
2005 2006 2007 2008 2009 2010 2011 2012 2013
0
2
4
6
8
10
12
14
16
ImpactFactor
EHJ 14.723
EJHF 6.577
CVR 5.808
EHJ supplements 5.64
EuroIntervention 3.75
EJPC 3.691
EHJCI 3.669
Europace 3.05
EJCN 1.828
The ESC Journal Family - IF

24. The ESC Journal Family on the Road Ahead
Many Thanks!